Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Hahn Mark W

SEC-identified person · CIK 1408502 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Soleno Therapeutics INC SLNO Director filed 2025 - 2026
Verona Pharma plc VRNA Chief Financial Officer filed 2021 - 2025
Alsp Orchid Acquisition Corp I ALOR Director filed 2021 - 2021
Dova Pharmaceuticals, Inc. DOVA Chief Financial Officer filed 2018 - 2019
Melinta Therapeutics, INC. /NEW/ MLNT EVP and CFO filed 2012 - 2017
Gigabeam Corp GGBM.PK Chief Financial Officer filed 2007 - 2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.